Jung-Ae Kim

12PUBLICATIONS
4CO-AUTHORS
Molecular targetsPredictive and prognostic markersBiologically active moleculesAutoimmunityOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 23, 2026
Therapeutic targeting of GSK-3β activation by the tyrosine kinase RYK in pancreatic ductal adenocarcinoma with BJ-2412, a novel sunitinib analogue.

|Mar 30, 2023
Induction of promyelocytic leukemia zinc finger protein by miR-200c-3p restores sensitivity to anti-androgen therapy in androgen-refractory prostate cancer and inhibits the cancer progression via down-regulation of integrin α3β4.

Sadan Dahal, Prakash Chaudhary, Jung-Ae Kim

|Mar 17, 2022
6-Amino-2,4,5-trimethylpyridin-3-ol and 2-amino-4,6-dimethylpyrimidin-5-ol derivatives as selective fibroblast growth factor receptor 4 inhibitors: design, synthesis, molecular docking, and anti-hepatocellular carcinoma efficacy evaluation.

Chhabi Lal Chaudhary, Dongchul Lim, Prakash Chaudhary

|Nov 13, 2021
TPH1 and 5-HT7 Receptor Overexpression Leading to Gemcitabine-Resistance Requires Non-Canonical Permissive Action of EZH2 in Pancreatic Ductal Adenocarcinoma.

Prakash Chaudhary, Diwakar Guragain, Jae-Hoon Chang

|Sep 28, 2021
Novel Pyridine Bioisostere of Cabozantinib as a Potent c-Met Kinase Inhibitor: Synthesis and Anti-Tumor Activity against Hepatocellular Carcinoma.

Ujjwala Karmacharya, Diwakar Guragain, Prakash Chaudhary

|May 06, 2020
Potent Inhibitory Effect of BJ-3105, a 6-Alkoxypyridin-3-ol Derivative, on Murine Colitis Is Mediated by Activating AMPK and Inhibiting NOX.

Pallavi Gurung, Sadan Dahal, Prakash Chaudhary

Pageof 2

Frequent Collaborators

3 joint publications

Byeong-Seon Jeong

1 joint publications

Tae-Gyu Nam

1 joint publications

Ujjwala Karmacharya

1 joint publications

Jae-Hoon Chang